3-AP and Gemcitabine in Treating Patients With Refractory Metastatic Breast Cancer
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of combining 3-AP with gemcitabine in treating
patients who have refractory metastatic breast cancer. Drugs used in chemotherapy, such as
3-AP and gemcitabine, work in different ways to stop tumor cells from dividing so they stop
growing or die. Combining 3-AP with gemcitabine may kill more tumor cells